2012
DOI: 10.1210/me.2012-1056
|View full text |Cite
|
Sign up to set email alerts
|

Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer

Abstract: Prostate tumor growth initially depends on androgens, which act via the androgen receptor (AR). Despite androgen ablation therapy, tumors eventually progress to a castrate-resistant stage in which the AR remains active. The mechanisms are poorly understood but it may be that changes in levels or activity of AR coregulators affect trafficking and activation of the receptor. A key stage in AR signaling occurs in the cytoplasm, where unliganded receptor is associated with the heat shock protein (HSP)90 foldosome … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
41
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(42 citation statements)
references
References 56 publications
1
41
0
Order By: Relevance
“…p23 is able to increase the AR protein level and AR transcriptional activity which is independent of its role in the HSP90 foldosome complex30. Significantly, p23 expression is implicated in resistance to HSP90 inhibitors28, and plays a role in PCa metastasis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…p23 is able to increase the AR protein level and AR transcriptional activity which is independent of its role in the HSP90 foldosome complex30. Significantly, p23 expression is implicated in resistance to HSP90 inhibitors28, and plays a role in PCa metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…p23 overexpression is induced on treatment with either androgens or anti-androgens and facilitates PCa cell motility; p23 knockdown inhibits the invasiveness of the PCa cell line LNCaP, suggesting an important role of p23 in PCa metastasis independent of its role as an HSP90 co-chaperone29. The expression of p23 increases AR protein level, AR ligand-binding activity and AR's target promoter-binding activity; most importantly, p23 functions to promote AR activity in an HSP90-independent mechanism involving the direct binding to AR30. p23 is also associated with an increased resistance to etoposide and doxorubicin in breast cancer cells31 along with elevated expression of a subset of estrogen-responsive genes32.…”
mentioning
confidence: 99%
“…Its co-chaperones are equally deemed as targets. P23 is among many of Hsp90 co-chaperone that is overexpressed in breast cancer [18], is involved in prostate cancer through androgen receptor activity [19] and is overexpressed in acute lymphoblastic leukemia where it inhibits chemotherapy-induced apoptosis [20].…”
Section: Hsp90mentioning
confidence: 99%
“…Probably these differences in the chaperones involved are driven by specific domains in estrogen or androgen receptors. In view of that, these HSPs are able to interact with ERs or AR stabilizating them (Reebye et al, 2012;Zoubeidi et al, 2007).…”
Section: Protective Effects Of 17β-estradiol and Testosterone On Satementioning
confidence: 99%